The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

24 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design and synthesis of new RAF kinase-inhibiting antiproliferative quinoline derivatives. Part 2: Diarylurea derivatives.EBI
University of Sharjah
Design, synthesis, and biological evaluation of new arylamide derivatives possessing sulfonate or sulfamate moieties as steroid sulfatase enzyme inhibitors.EBI
University of Sharjah
Design, synthesis, and qualitative structure-activity evaluations of novelß-secretase inhibitors as potential Alzheimer's drug leads.EBI
University of Sharjah
Rational design and synthesis of potent dibenzazepine motifs as beta-secretase inhibitors.EBI
University of Sharjah
Synthesis, biological evaluation, and stability studies of raloxifene mono- and bis-sulfamates as dual-targeting agents.EBI
University of Sharjah
Design and synthesis of new adamantyl derivatives as promising antiproliferative agents.EBI
University of Sharjah
Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19.EBI
University of Sharjah
Diarylamides in anticancer drug discovery: A review of pre-clinical and clinical investigations.EBI
University of Sharjah
Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitors.EBI
University of Sharjah
Design and synthesis of new quinoline derivatives as selective C-RAF kinase inhibitors with potent anticancer activity.EBI
University of Sharjah
Efficient selective targeting of EBI
University of Sharjah
Evaluation of imidazo[2,1-b]thiazole-based anticancer agents in one decade (2011-2020): Current status and future prospects.EBI
University of Sharjah
Discovery of novel class of histone deacetylase inhibitors as potential anticancer agents.EBI
University of Sharjah
Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells.EBI
University of Sharjah
A new series of aryl sulfamate derivatives: Design, synthesis, and biological evaluation.EBI
University of Sharjah
Discovery of highly potent V600E-B-RAF kinase inhibitors: Molecular modeling study.EBI
University of Sharjah
Sulfamates in drug design and discovery: Pre-clinical and clinical investigations.EBI
University of Sharjah
Sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as potent carbonic anhydrase II/IX/XII inhibitors.EBI
University of Sharjah
Synthesis, biological evaluation, and molecular docking study of sulfonate derivatives as nucleotide pyrophosphatase/phosphodiesterase (NPP) inhibitors.EBI
University of Sharjah
Discovery of a potent p38α/MAPK14 kinase inhibitor: Synthesis, in vitro/in vivo biological evaluation, and docking studies.EBI
University of Sharjah
Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase.EBI
University of Sharjah
Synthesis, in vitro antiproliferative activity, and kinase inhibitory effects of pyrazole-containing diarylureas and diarylamides.EBI
University of Sharjah
Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors.EBI
University of Sharjah
Design, synthesis and SAR analysis of potent BACE1 inhibitors: Possible lead drug candidates for Alzheimer's disease.EBI
University of Sharjah